J Breast Cancer.  2013 Sep;16(3):354-355. 10.4048/jbc.2013.16.3.354.

Neutrophil to Lymphocyte Ratio May Predict Mortality in Breast Cancer Patients

• Balta S
• Demirkol S
• Kucuk U
• Sarlak H
• Kurt O
• Arslan Z

• KMID: 2286390
• DOI: http://doi.org/10.4048/jbc.2013.16.3.354

Abstract

No abstract available.

MeSH Terms

Breast
Breast Neoplasms
Humans
Lymphocytes
Neutrophils

Reference

1. Noh H, Eomm M, Han A. Usefulness of pretreatment neutrophil to lymphocyte ratio in predicting disease-specific survival in breast cancer patients. J Breast Cancer. 2013; 16:55–59.

2. Lee JA, Bae JW, Woo SU, Kim H, Kim CH. D2-40, podoplanin, and CD31 as a prognostic predictor in invasive ductal carcinomas of the breast. J Breast Cancer. 2011; 14:104–111.

3. Demirkol S, Balta S, Unlu M, Yuksel UC, Celik T, Arslan Z, et al. Evaluation of the mean platelet volume in patients with cardiac syndrome X. Clinics (Sao Paulo). 2012; 67:1019–1022.

4. Azab B, Shah N, Radbel J, Tan P, Bhatt V, Vonfrolio S, et al. Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients. Med Oncol. 2013; 30:432.

5. Azab B, Bhatt VR, Phookan J, Murukutla S, Kohn N, Terjanian T, et al. Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients. Ann Surg Oncol. 2012; 19:217–224.

6. Wang S, Zhang Z, Fang F, Gao X, Sun W, Liu H. The neutrophil/lymphocyte ratio is an independent prognostic indicator in patients with bone metastasis. Oncol Lett. 2011; 2:735–740.

7. Cingoz F, Iyisoy A, Demirkol S, Sahin MA, Balta S, Celik T, et al. Carotid intima-media thickness in patients with slow coronary flow and its association with neutrophil-to-lymphocyte ratio: a preliminary report. Clin Appl Thromb Hemost. Epub 2013 Apr 23. http://dx.doi.org/10.1177/1076029613485283.

8. Demirkol S, Balta S, Unlu M, Arslan Z, Cakar M, Kucuk U, et al. Neutrophils/lymphocytes ratio in patients with cardiac syndrome X and its association with carotid intima-media thickness. Clin Appl Thromb Hemost. Epub 2012 Nov 26. http://dx.doi.org/10.1177/1076029612467227.

9. Balta S, Cakar M, Demirkol S, Arslan Z, Akhan M. Higher neutrophil to lymhocyte ratio in patients with metabolic syndrome. Clin Appl Thromb Hemost. Epub 2013 Jan 23. http://dx.doi.org/10.1177/1076029612475023.

10. Karaman M, Balta S, Ay SA, Cakar M, Naharci I, Demirkol S, et al. The comparative effects of valsartan and amlodipine on vWf levels and N/L ratio in patients with newly diagnosed hypertension. Clin Exp Hypertens. Epub 2013 Jan 4. http://dx.doi.org/10.3109/10641963.2012.758734.

11. Demirkol S, Balta S, Cakar M, Unlu M, Arslan Z, Kucuk U. Red cell distribution width: a novel inflammatory marker in clinical practice. Cardiol J. 2013; 20:209.

12. Cakar M, Sarlak H, Balta S, Unlu M, Demirbas S, Demirkol S. Serum uric acid still carries controversies about its role in endothelial dysfunction. J Clin Hypertens (Greenwich). 2013; 15:296.